TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three months ended March 31, 2026 with the Canadian securities authorities. These documents may be viewed under the Company's profile at www.sedarplus.com.
"We are pleased to report a strong start to the year, achieving 11% annual organic ARR⁽¹⁾ growth and 25% adjusted EBITDA as a percentage of revenue⁽¹⁾," said Dan Matlow, CEO of VitalHub. "Our recent acquisitions are supporting growth, and integration work is progressing well as we drive operational efficiency. We are pleased with first quarter billings and renewals across the entire organization. We continue to strengthen our balance sheet and increase our capacity for acquisitions."
VitalHub's quarterly investor conference call will take place on Friday, May 8, 2026, at 9:00am EST. To register for the conference call please visit: https://us06web.zoom.us/webinar/register/WN_whpHyhutQhyBxYBelYnzDA#/registration
First Quarter 2026 Highlights
ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $96,149,750 at December 31, 2025, an increase of $2,929,059 or 3%.Over the previous quarter, ARR movement in Q1 2026 from Q4 2025 was attributable to the following:
Organic growth of $2,729,378 or 3%.
Gain of $199,681 due to fluctuations in foreign exchange rates.
ARR⁽¹⁾ as at March 31, 2026 was $99,078,809 as compared to $73,687,666 at March 31, 2025, an increase of $25,391,143 or 34%.Over the previous year, ARR movement in Q1 2026 from Q1 2025 was attributable to the following:
Organic growth of $8,182,967 or 11%.
Acquisition growth of $15,870,000 or 22%.
Gain of $1,338,176 due to fluctuations in foreign exchange rates.
Revenue of $31,906,402 as compared to $21,674,966 in the equivalent prior year period, an increase of $10,231,436 or 47%.
Gross profit as a percentage of revenue was 82% in Q1 2026 as compared to 80% in the equivalent prior year period.
Net income before income taxes of $3,602,054 as compared to $1,487,413 in the equivalent prior year period.
Net income of $2,355,117 as compared to $1,161,472 in the equivalent prior year period.
EBITDA⁽¹⁾ of $6,528,302 as compared to $3,150,374 in the equivalent prior year period.
Adjusted EBITDA⁽¹⁾ of $7,989,761 or 25% of revenue as compared to $5,614,686 or 26% of revenue in the equivalent prior year period, an increase of $2,375,075 or 42%.
Cash and cash equivalents and short-term investments as at March 31, 2026 was $121,266,957 compared to $119,180,625 as at December 31, 2025.
(1) Non-IFRS or supplementary financial measure.
Selected Financial Information
Three months ended
March 31, 2026
% Revenue
March 31, 2025
% Revenue
Change
$
$
%
Revenue
31,906,402
100%
21,674,966
100%
47%
Cost of sales
5,861,731
18%
4,230,673
20%
(39%)
Gross profit
26,044,671
82%
17,444,293
80%
49%
Operating expenses
General and administrative
5,764,464
18%
5,270,749
24%
(9%)
Sales and marketing
3,015,286
9%
2,029,012
9%
(49%)
Research and development
9,037,069
28%
5,220,183
24%
(73%)
Depreciation of property and equipment
138,842
0%
142,077
1%
2%
Depreciation of right-of-use assets
168,579
1%
119,896
1%
